Matches in Wikidata for { <http://www.wikidata.org/entity/Q65542792> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q65542792 description "clinical trial" @default.
- Q65542792 description "ensayu clínicu" @default.
- Q65542792 description "klinisch onderzoek" @default.
- Q65542792 description "клінічне випробування" @default.
- Q65542792 description "կլինիկական փորձարկում" @default.
- Q65542792 name "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 name "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 type Item @default.
- Q65542792 label "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 label "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 prefLabel "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 prefLabel "Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children" @default.
- Q65542792 P1050 Q65542792-1B1AE326-9B29-4093-A171-ED0714FDB3AF @default.
- Q65542792 P1050 Q65542792-8EB61B8E-1FD9-4862-B83D-B71D5A1396EA @default.
- Q65542792 P1132 Q65542792-84E9586F-5574-4D86-B862-6CBC0DD289C0 @default.
- Q65542792 P1476 Q65542792-50091456-B5B1-47F3-A269-74741D5FE108 @default.
- Q65542792 P17 Q65542792-1EE85340-C85F-4285-8D9F-DB17990968BA @default.
- Q65542792 P17 Q65542792-F988E626-B585-45E3-87A6-59356C3E4F71 @default.
- Q65542792 P3098 Q65542792-AF1E9CF3-AD8B-426F-BDFB-F37219A201FA @default.
- Q65542792 P31 Q65542792-B1A7D97C-BDEA-4CF9-95A2-1B66DF3D9427 @default.
- Q65542792 P580 Q65542792-A4167B06-47B8-4187-84E7-679902A48898 @default.
- Q65542792 P582 Q65542792-CD6A87FA-0373-4412-9493-A3108A6F193E @default.
- Q65542792 P6099 Q65542792-7C3E067C-F377-4E85-BD2D-ADFEC875B435 @default.
- Q65542792 P6153 Q65542792-AF51EEBB-48F8-487D-A271-A2ED78350430 @default.
- Q65542792 P8363 Q65542792-0EE09F3A-0367-410F-903B-FA53E179E537 @default.
- Q65542792 P859 Q65542792-55D04C8E-DE0C-43CC-B9DF-41D970449FDA @default.
- Q65542792 P1050 Q134649 @default.
- Q65542792 P1050 Q6853 @default.
- Q65542792 P1132 "+1290" @default.
- Q65542792 P1476 "Assess Reactogenicity & Safety of a Booster of Either Tritanrix™-HepB/Hib-MenAC or Tritanrix™-HepB/Hiberix™ Given (Single-blind) at 15-18 (Philippines)/15-24 Mths (Thailand) & a Dose of Mencevax™ ACWY at 24-30 Mths (Open Label)" @default.
- Q65542792 P17 Q869 @default.
- Q65542792 P17 Q928 @default.
- Q65542792 P3098 "NCT00228917" @default.
- Q65542792 P31 Q30612 @default.
- Q65542792 P580 "2005-06-01T00:00:00Z" @default.
- Q65542792 P582 "2006-01-01T00:00:00Z" @default.
- Q65542792 P6099 Q42824827 @default.
- Q65542792 P6153 Q212322 @default.
- Q65542792 P8363 Q78089383 @default.
- Q65542792 P859 Q212322 @default.